Pancreatic Cancer Patient's Journey: From Despair to Hope with Clinical Trial (2026)

Hernando Salcedo, an 83-year-old grandfather, was diagnosed with Stage III pancreatic cancer. Traditional chemotherapy had severe side effects, but a clinical trial using a new chemotherapy delivery system called RenovoCath offered hope. This system delivers chemotherapy directly to the tumor site, reducing side effects and improving survival rates. Salcedo's quality of life improved significantly, allowing him to participate in family events and plan for the future. While his prognosis remains uncertain, the extra time and improved well-being feel like 'winning the lottery' to his family.